MJ

Director Director DIN 06813097
DIN 06813097 First appointment Mar 2014 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Mukes Jha

Data last updated:

Mukes Jha was a Director at Confiance Pharmaceuticals Private Limited (2016–2019) and Director at Fedes Medicos Private Limited (from 2014). The companies operate in Pharma.

DIN 06813097
Primary Designation Director
Industry Pharma
First Appointment 20 Mar 2014
Oldest Company Age 12 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Jun 20162016₹11.7 Lakh (FY 2025)Active
Fedes Medicos Private Limited U24232BR2014PTC022238
Director20 Mar 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Fedes Medicos Private Limited
Confiance Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mukes Jha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mukes Jha

Mukes Jha was first appointed on 20 Mar 2014 as Director at Fedes Medicos Private Limited. The most recent appointment on record is 22 Jun 2016 at Confiance Pharmaceuticals Private Limited.

Mukes Jha held 2 earlier board appointments: Confiance Pharmaceuticals Private Limited (Director, 22 Jun 2016 to 22 Apr 2019); Fedes Medicos Private Limited (Director, from 20 Mar 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available